Xavier Stevens Samuel, Jackson Christopher G C A, Karikios Deme
Department of Cancer Care and Epidemiology, Sinclair Cancer Research Institute, Queen's University, Kingston, Canada.
Faculty of Medicine and Health, University of Sydney, Australia.
Lancet Reg Health West Pac. 2025 Aug 12;61:101660. doi: 10.1016/j.lanwpc.2025.101660. eCollection 2025 Aug.
Established in 2023, Common Sense Oncology (CSO) is a grass roots initiative uniting cancer clinicians, policymakers, academics, patients and their advocates that calls for a 'recalibration' of cancer care to focus on outcomes that matter to patients. CSO emphasises treatments that substantially improve survival and quality of life, and advocates for equitable global access to effective cancer therapies. This article examines the potential of CSO principles to improve cancer care in the Western Pacific, a geographically and culturally diverse region that shoulders one-third of the global cancer burden. We review early progress of CSO working groups and identify regional challenges, such as engaging diverse membership, fostering local change, and evaluating impact. Unique regional strengths, such as longstanding cooperative trial group and China's growing influence in global drug development, are highlighted.
常识肿瘤学（CSO）成立于2023年，是一项基层倡议，联合了癌症临床医生、政策制定者、学者、患者及其倡导者，呼吁对癌症护理进行“重新校准”，以关注对患者至关重要的结果。CSO强调能显著提高生存率和生活质量的治疗方法，并倡导在全球范围内公平获得有效的癌症治疗。本文探讨了CSO原则在西太平洋地区改善癌症护理的潜力，该地区地域和文化多样，承担着全球三分之一的癌症负担。我们回顾了CSO工作组的早期进展，并确定了区域挑战，如吸引不同成员、促进地方变革和评估影响。还强调了该地区独特的优势，如长期存在的合作试验组以及中国在全球药物开发中日益增长的影响力。
